6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Disease-Specific Regenerative Medicine
Precision approaches are driving innovation in disease-specific regenerative medicine, where therapies are designed to meet the distinct requirements of conditions like Parkinson’s, type 1 diabetes, and osteoarthritis. By targeting disease mechanisms, researchers employ tailored stem cell lines, responsive scaffolds, and signaling molecules to regenerate affected tissues more effectively. Integration of genetic profiling and cellular engineering enables treatments that address not only structural damage but also underlying pathophysiology. Disease-specific regenerative medicine brings personalized medicine closer to reality by aligning molecular pathology with regenerative tools. This targeted approach reduces risks of immune rejection and improves therapeutic efficacy, especially in chronic and degenerative conditions with limited treatment options.
Marco Polettini
DVM, Italy
Sergey Suchkov
The Russian University of Medicine and The Russian Academy of Natural Sciences, Russian Federation
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United KingdomSubmit your abstract Today
Title :
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, The Russian University of Medicine and The Russian Academy of Natural Sciences, Russian Federation
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title :
Marco Polettini, DVM, Italy
Title :
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Personalized and Precision Medicine PPM as a unique healthcare model via pathology related modeling biodesign inspired translational applications and clinical practice of the next step generation to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and The Russian Academy of Natural Sciences, Russian Federation